Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

ABBOTINDIA's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 2.75500
forwardPE 33.75846
debtToEquity 4.54900
earningsGrowth 0.15800
revenueGrowth 0.07600
grossMargins 0.45773
operatingMargins 0.27518
trailingEps 709.15000
forwardEps 0.00000

ABBOTINDIA's current ratio of 2.755 highlights the company's solid liquidity, indicating that it can easily service its short-term debt. ABBOTINDIA's ample cash reserves and current assets ensure that the company is well-positioned to meet its immediate financial liabilities.
ABBOTINDIA's positive gross and operating margins indicate strong financial performance. These margins show that the company is profitable and efficient in its operations, with effective cost control contributing to its overall financial success.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

The price of ABBOTINDIA has consistently remained close to the lower end of price projections. This trend may reflect uncertainty in the market regarding the company's ability to deliver on growth expectations.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


Analysts' buy bias for ABBOTINDIA signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to ABBOTINDIA, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.